KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teladoc Health (TDOC) Common Equity (2016 - 2025)

Teladoc Health (TDOC) has disclosed Common Equity for 13 consecutive years, with $1.4 billion as the latest value for Q4 2025.

  • Quarterly Common Equity fell 7.07% to $1.4 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.4 billion through Dec 2025, down 7.07% year-over-year, with the annual reading at $1.4 billion for FY2025, 7.07% down from the prior year.
  • Common Equity hit $1.4 billion in Q4 2025 for Teladoc Health, roughly flat from $1.4 billion in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $16.0 billion in Q4 2021 to a low of $1.4 billion in Q4 2025.
  • Historically, Common Equity has averaged $5.5 billion across 5 years, with a median of $2.3 billion in 2023.
  • Biggest five-year swings in Common Equity: soared 1482.67% in 2021 and later crashed 85.62% in 2022.
  • Year by year, Common Equity stood at $16.0 billion in 2021, then plummeted by 85.62% to $2.3 billion in 2022, then grew by 0.79% to $2.3 billion in 2023, then tumbled by 35.9% to $1.5 billion in 2024, then dropped by 7.07% to $1.4 billion in 2025.
  • Business Quant data shows Common Equity for TDOC at $1.4 billion in Q4 2025, $1.4 billion in Q3 2025, and $1.4 billion in Q2 2025.